In line with respective poor clinical outcome, positive ABCB1 AML overexpressed CD34, BAALC, and CD200. Apart from visualizing co-regulated gene expression, this analysis gave further insights into the inherent heterogeneity of AML with regard to ABCB1. The gene discussed is CD34; the disease is acute myeloid leukemia.